Cytek Biosciences, Inc. CTKB Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$18.87M+57.2% | -$44.08M-705% | -$5.48M+1.9% | -$5.58M+51.0% | -$11.4M— | ||
| $1.87M-1.6% | $1.9M-1.1% | $1.92M+1.5% | $1.89M+0.8% | $1.88M+1.1% | ||
| $4.86M-12.0% | $5.53M-2.0% | $5.64M-17.0% | $6.79M+2.4% | $6.63M-5.3% | ||
| -$2.74M-255% | -$771K+80.2% | -$3.9M— | $0+100% | -$125K-106% | ||
| $2.17M+117% | $1M+52.4% | $657K-58.3% | $1.58M+85.7% | $849K-5.0% | ||
| -$27.08M— | —— | $18.92M+215% | -$16.41M-274% | $9.45M+115% | ||
| $0— | —— | —— | $4.51M-57.6% | $10.63M+51.8% | ||
| $5.07M+258% | $1.42M-32.3% | $2.09M+51.0% | $1.39M+101% | $690K-75.2% | ||
| $869K-70.4% | $2.94M+1,928% | $145K+2.1% | $142K-90.6% | $1.52M+992% | ||
| $3.98M+425% | -$1.23M— | —— | -$2.6M+77.5% | -$11.55M-217% | ||
| -$25.19M-938% | -$2.43M— | —— | -$19.83M-475% | -$3.45M+94.6% | ||
| -$4.9M-177% | -$1.77M+61.1% | -$4.56M-210% | -$1.47M-50.8% | -$974K-188% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Cytek Biosciences, Inc. generate?
- Cytek Biosciences, Inc. (CTKB) generated -$7.4M in operating cash flow over the trailing twelve months.
- What is Cytek Biosciences, Inc.'s free cash flow?
- After $5.4M of capital expenditures, Cytek Biosciences, Inc.'s free cash flow was -$12.7M over the trailing twelve months, down 172.6% year over year.
- Where does Cytek Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from Cytek Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
